BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ali T, Yun L, Rubin DT. Risk of post-operative complications associated with anti-TNF therapy in inflammatory bowel disease. World J Gastroenterol 2012; 18(3): 197-204 [PMID: 22294822 DOI: 10.3748/wjg.v18.i3.197]
URL: https://www.wjgnet.com/1007-9327/full/v18/i3/197.htm
Number Citing Articles
1
Kiyoshi Maeda, Hisashi Nagahara, Masatsune Shibutani, Hiroshi Otani, Katsunobu Sakurai, Takahiro Toyokawa, Hiroaki Tanaka, Naoshi Kubo, Kazuya Muguruma, Noriko Kamata, Hirokazu Yamagami, Kosei Hirakawa. A preoperative low nutritional prognostic index correlates with the incidence of incisional surgical site infections after bowel resection in patients with Crohn’s diseaseSurgery Today 2015; 45(11): 1366 doi: 10.1007/s00595-014-1044-8
2
Dario Sorrentino, Sandy Fogel, Johan Van den Bogaerde. Surgery for Crohn’s disease and anti-TNF agents: the changing scenarioExpert Review of Gastroenterology & Hepatology 2013; 7(8): 689 doi: 10.1586/17474124.2013.842895
3
Andrei Dan, Marylise Boutros, Hacene Nedjar, Uri Kopylov, Waqqas Afif, Maria Abou Khalil, Elham Rahme. Cost of Ulcerative Colitis in Quebec, CanadaInflammatory Bowel Diseases 2017; 23(8): 1262 doi: 10.1097/MIB.0000000000001147
4
Cheryl Lau, Marla Dubinsky, Gil Melmed, Eric Vasiliauskas, Dror Berel, Dermot McGovern, Andrew Ippoliti, David Shih, Stephan Targan, Phillip Fleshner. The Impact of Preoperative Serum Anti-TNFα Therapy Levels on Early Postoperative Outcomes in Inflammatory Bowel Disease SurgeryAnnals of Surgery 2015; 261(3): 487 doi: 10.1097/SLA.0000000000000757
5
Anita Afzali, Christopher J. Park, Kehao Zhu, Jie Kate Hu, Prachi Sharma, Mika N. Sinanan, Scott D. Lee. Preoperative Use of Methotrexate and the Risk of Early Postoperative Complications in Patients with Inflammatory Bowel DiseaseInflammatory Bowel Diseases 2016; 22(8): 1887 doi: 10.1097/MIB.0000000000000780
6
N. Horesh, M. R. Freund, Z. Garoufalia, R. Gefen, D. Zhang, T. Smith, S. H. Emile, S. D. Wexner. Biological therapy prior to repeat ileocolic resection in Crohn’s disease can reduce the postoperative complication rateTechniques in Coloproctology 2023; 27(4): 291 doi: 10.1007/s10151-022-02702-0
7
Kun Guo, Jianan Ren, Guanwei Li, Qiongyuan Hu, Xiuwen Wu, Zhiwei Wang, Gefei Wang, Guosheng Gu, Huajian Ren, Zhiwu Hong, Jieshou Li. Risk factors of surgical site infections in patients with Crohn’s disease complicated with gastrointestinal fistulaInternational Journal of Colorectal Disease 2017; 32(5): 635 doi: 10.1007/s00384-017-2751-6
8
Kim C. Lu, Steven R. Hunt. Surgical Management of Crohn's DiseaseSurgical Clinics of North America 2013; 93(1): 167 doi: 10.1016/j.suc.2012.09.002
9
Bradley Davis, David E. Rivadeneira. Complications of Colorectal AnastomosesSurgical Clinics of North America 2013; 93(1): 61 doi: 10.1016/j.suc.2012.09.014
10
Xiaoping Luo, Zhilun Yu, Chao Deng, Jingjing Zhang, Gaiyan Ren, Aning Sun, Sridhar Mani, Zhengtao Wang, Wei Dou. Baicalein ameliorates TNBS-induced colitis by suppressing TLR4/MyD88 signaling cascade and NLRP3 inflammasome activation in miceScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-12562-6
11
Takayuki Yamamoto, Manabu Shiraki. Risk Assessment of Postoperative Complications in Crohn’s DiseaseDiseases of the Colon & Rectum 2013; 56(3): e33 doi: 10.1097/DCR.0b013e31827cd045
12
Rogério SAAD HOSSNE, Ligia Yukie SASSAKI, Julio Pinheiro BAIMA, José Donizeti de MEIRA JÚNIOR, Luana Moraes CAMPOS. ANALYSIS OF RISK FACTORS AND POSTOPERATIVE COMPLICATIONS IN PATIENTS WITH CROHN’S DISEASEArquivos de Gastroenterologia 2018; 55(3): 252 doi: 10.1590/s0004-2803.201800000-63
13
Ingrid Jouvin, Jérémie H Lefevre, Ben Creavin, Sophie Pitel, Najim Chafai, Emmanuel Tiret, Laurent Beaugerie, Yann Parc. Postoperative Morbidity Risks Following Ileocolic Resection for Crohn’s Disease Treated With Anti-TNF Alpha Therapy: A Retrospective Study of 360 PatientsInflammatory Bowel Diseases 2018; 24(2): 422 doi: 10.1093/ibd/izx036
14
Kiyoshi Maeda, Hisashi Nagahara, Masatsune Shibutani, Tatsunari Fukuoka, Yasuhito Iseki, Shinji Matsutani, Takahiro Toyokawa, Hiroaki Tanaka, Kazuya Muguruma, Hirokazu Yamagami, Kosei Hirakawa, Masaichi Ohira. Preoperative Neutrophil-to-Lymphocyte Ratio Is Correlated with Severe Postoperative Complications After Emergency Surgery for Ulcerative ColitisInternational Surgery 2019; 104(11-12): 514 doi: 10.9738/INTSURG-D-16-00216.1
15
C.-T. Germer, C. Isbert. Operative Therapie chronisch-entzündlicher DarmerkrankungenDer Internist 2014; 55(8): 918 doi: 10.1007/s00108-013-3444-z
16
Xiaoqi Huang, Zhiwei Chen, Minyao Li, Yaomin Zhang, Shijie Xu, Haiyang Huang, Xiaoli Wu, Xuebao Zheng. Herbal pair Huangqin-Baishao: mechanisms underlying inflammatory bowel disease by combined system pharmacology and cell experiment approachBMC Complementary Medicine and Therapies 2020; 20(1) doi: 10.1186/s12906-020-03068-2
17
Weiming Zhu, Zhen Guo, Lugen Zuo, Jianfeng Gong, Yi Li, Lili Gu, Lei Cao, Ning Li, Jieshou Li. CONSORTMedicine 2015; 94(29): e1175 doi: 10.1097/MD.0000000000001175
18
Jennifer S. Davids, Justin A. Maykel. The ASCRS Textbook of Colon and Rectal Surgery2016; : 93 doi: 10.1007/978-3-319-25970-3_6
19
Abel Botelho Quaresma, Fernanda da Silva Barbosa Baraúna, Fábio Vieira Teixeira, Rogério Saad-Hossne, Paulo Gustavo Kotze. Exploring the Relationship between Biologics and Postoperative Surgical Morbidity in Ulcerative Colitis: A ReviewJournal of Clinical Medicine 2021; 10(4): 710 doi: 10.3390/jcm10040710
20
Ryan Nelson, Chuanhong Liao, Alessandro Fichera, David T. Rubin, Joel Pekow. Rescue Therapy with Cyclosporine or Infliximab is not Associated with an Increased Risk for Postoperative Complications in Patients Hospitalized for Severe Steroid-refractory Ulcerative ColitisInflammatory Bowel Diseases 2014; 20(1): 14 doi: 10.1097/01.MIB.0000437497.07181.05
21
Hang Hock Shim, Christopher Ma, Paulo G Kotze, Cynthia H Seow, Heba Al-Farhan, Ahmed K Al-Darmaki, Jack X Q Pang, Richard N Fedorak, Shane M Devlin, Levinus A Dieleman, Gilaad G Kaplan, Kerri L Novak, Karen I Kroeker, Brendan P Halloran, Remo Panaccione. Preoperative Ustekinumab Treatment Is Not Associated With Increased Postoperative Complications in Crohn’s Disease: A Canadian Multi-Centre Observational Cohort StudyJournal of the Canadian Association of Gastroenterology 2018; 1(3): 115 doi: 10.1093/jcag/gwy013
22
Mark A. Samaan, Preet Bagi, Niels Vande Casteele, Geert R. D’Haens, Barrett G. Levesque. An Update on Anti-TNF Agents in Ulcerative ColitisGastroenterology Clinics of North America 2014; 43(3): 479 doi: 10.1016/j.gtc.2014.05.006
23
Neha Deshpande, Gabrielle Berger. The Perioperative Medicine Consult Handbook2020; : 151 doi: 10.1007/978-3-030-19704-9_18
24
Carlo Selmi, Angela Ceribelli, Stanley M Naguwa, Luca Cantarini, Yehuda Shoenfeld. Safety issues and concerns of new immunomodulators in rheumatologyExpert Opinion on Drug Safety 2015; 14(3): 389 doi: 10.1517/14740338.2015.993605
25
Ron G. Landmann, Todd D. Francone. The ASCRS Textbook of Colon and Rectal Surgery2022; : 95 doi: 10.1007/978-3-030-66049-9_6
26
Alaa El-Hussuna, Pär Myrelid, Stefan D Holubar, Paulo G Kotze, Graham Mackenzie, Gianluca Pellino, Des Winter, Justin Davies, Ionut Negoi, Perbinder Grewal, Gaetano Gallo, Kapil Sahnan, Ines Rubio-Perez, Daniel Clerc, Nicolas Demartines, James Glasbey, Miguel Regueiro, Ahmed E Sherif, Peter Neary, Francesco Pata, Mark Silverberg, Stefan Clermont, Sami A Chadi, Sameh Emile, Nicolas Buchs, Monica Millan, Ana Minaya-Bravo, Hossam Elfeki, Veronica De Simone, Mostafa Shalaby, Celestino Gutierrez, Cihan Ozen, Ali Yalçınkaya, David Rivadeneira, Alssandro Sturiale, Nuha Yassin, Antonino Spinelli, Jay Warusavitarne, Argyrios Ioannidis, Steven Wexner, Julio Mayol. Biological Treatment and the Potential Risk of Adverse Postoperative Outcome in Patients With Inflammatory Bowel Disease: An Open-Source Expert Panel Review of the Current Literature and Future PerspectivesCrohn's & Colitis 360 2019; 1(3) doi: 10.1093/crocol/otz021
27
Gabrielle Berger. The Perioperative Medicine Consult Handbook2015; : 115 doi: 10.1007/978-3-319-09366-6_17
28
José Luis Cabriada, Isabel Vera, Eugeni Domènech, Manuel Barreiro-de Acosta, María Esteve, Javier P. Gisbert, Julia Panés, Fernando Gomollón. Recomendaciones del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa sobre el uso de fármacos antifactor de necrosis tumoral α en la enfermedad inflamatoria intestinal (2013)Gastroenterología y Hepatología 2013; 36(3): 127 doi: 10.1016/j.gastrohep.2013.01.002
29
G Li, J Ren, G Wang, D Hu, G Gu, S Liu, H Ren, X Wu, J Li. Preoperative exclusive enteral nutrition reduces the postoperative septic complications of fistulizing Crohn’s diseaseEuropean Journal of Clinical Nutrition 2014; 68(4): 441 doi: 10.1038/ejcn.2014.16
30
Sandra M. Quezada, Leon P. McLean, Raymond K. Cross. Adverse events in IBD therapy: the 2018 updateExpert Review of Gastroenterology & Hepatology 2018; 12(12): 1183 doi: 10.1080/17474124.2018.1545574
31
S. R. Brown, N. S. Fearnhead, O. D. Faiz, J. F. Abercrombie, A. G. Acheson, R. G. Arnott, S. K. Clark, S. Clifford, R. J. Davies, M. M. Davies, W. J. P. Douie, M. G. Dunlop, J. C. Epstein, M. D. Evans, B. D. George, R. J. Guy, R. Hargest, A. B. Hawthorne, J. Hill, G. W. Hughes, J. K. Limdi, C. A. Maxwell‐Armstrong, P. R. O'Connell, T. D. Pinkney, J. Pipe, P. M. Sagar, B. Singh, M. Soop, H. Terry, J. Torkington, A. Verjee, C. J. Walsh, J. H. Warusavitarne, A. B. Williams, G. L. Williams, R. G. Wilson. The Association of Coloproctology of Great Britain and Ireland consensus guidelines in surgery for inflammatory bowel diseaseColorectal Disease 2018; 20(S8): 3 doi: 10.1111/codi.14448